Notice
Notice Regarding Expiry of Lock-in Period and Release of Shares of Sopan Pharmaceuticals Limited
Sopan Pharmaceuticals Limited has issued a notice regarding the completion of the lock-in period of shares allocated to the Collective Investment Fund and the subsequent release of such shares in accordance with the applicable regulatory provisions.
Sopan Pharmaceuticals Limited has published a notice regarding the expiry of the lock-in period applicable to shares allocated to the Collective Investment Fund.
As stated in the notice, 214,500 ordinary shares of Sopan Pharmaceuticals Limited were allocated to the Collective Investment Fund in connection with the company's public issue. In accordance with the applicable provisions of the Collective Investment Fund Regulations, 2067 and the directives of the Securities Board of Nepal (SEBON), such shares were required to remain under a lock-in period for six months from the date of allotment.
The company has informed the concerned authorities that the applicable lock-in period is coming to an end and has requested the necessary publication and record update regarding the release of the shares from the lock-in period.
The notice has been addressed to the Securities Board of Nepal (SEBON) and CDS and Clearing Limited, with information provided to the Nepal Stock Exchange Limited (NEPSE) and other concerned parties.
